Monitoring Agency report for the quarter ended December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CARE Ratings has filed its Monitoring Agency Report for Eraaya Lifespaces' preferential issue of compulsorily convertible warrants for Q3FY26. The original issue size of Rs. 1,028.70 crore was cut to Rs. 218.70 crore after undersubscription, of which Rs. 115.67 crore was raised and nearly all (Rs. 115.64 crore) utilised by December 31, 2025. CARE flagged procedural deviations including Rs. 1,770 in bank charges spent without board approval and Rs. 9.02 crore transferred to an individual (Sneha Garg) for the investment-in-subsidiaries object without supporting documents, though it deemed this 7.22% deviation non-material. The report also highlights serious concerns: H1FY26 results remain unpublished, USD 40 million in FCCB proceeds for the Ebix acquisition are stuck in UK litigation, a Vikas Lifecare arbitration award of USD 34.83 million is unpaid, ED raids were conducted on the promoter's premises in November 2025 in the Mahadev Betting App case, and there have been frequent changes in top management and a subsidiary auditor's resignation.
The accumulation of governance lapses, regulatory scrutiny (ED raids), ongoing legal disputes, and delayed financial reporting raises material red flags for shareholders. Investors should monitor the outcomes of the UK FCCB litigation, the unpaid arbitration award, and the ED investigation, as adverse rulings could significantly affect the company's financial standing and stock price.